Prosecution Insights
Last updated: October 25, 2026

Chr. Hansen A/S

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

28 pending office actions • 10 art units • 25 examiners • 0 of 28 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Analysis

Chr. Hansen A/S has 29 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 26 examiners and 11 art units, combining wide examiner distribution with repeated art-unit involvement. That structure makes coordination important: examiner-specific responses must remain distinct, while recurring art-unit issues can be tracked across related matters.

LI, CHANGQING is the busiest examiner, with 2 pending matters. The assignment is small relative to the full portfolio, confirming that prosecution is not concentrated in one examiner’s docket. The larger difference between examiner and art-unit counts also suggests that art-unit-level review may reveal more continuity than examiner-level review.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

28
Total Pending OAs
14
Non-Final OAs
14
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
4
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (4)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

13
Hard (46%)
14
Medium (50%)
1
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (14%)
§103 only11 (39%)
§112 only1 (4%)
Double-patenting + other3 (11%)
Multi-statute (no §101)9 (32%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

27
Life Sciences
96% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
4% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

280 h
Manual time on pending OAs
56 h
Time saved (low, 20%)
98 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AFREMOVA, VERA 2 50.5% +29.4%
MORNHINWEG, JEFFREY P 2 36.7% +32.2%
TURNER, FELICIA C 2 26.2% +30.2%
KERSHAW, KELLY P 1 17.7% +16.0%
MUKHOPADHYAY, BHASKAR 1 28.2% +37.0%
LI, CHANGQING 1 29.2% +33.1%
BERKE-SCHLESSEL, DAVID W 1 66.8% +31.5%
HAWKINS, AMANDA SALATA 1 15.4% +40.9%
FERNANDEZ, SUSAN EMILY 1 52.3% +60.9%
TSAY, MARSHA M 1 45.5% +52.8%

Hard Cases (16)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
16769964 SPRAY-DRIED SIALYLLACTOSE SPANGLER, JOSEPH RANKIN 80d overdue
18267958 Microbial Cells Possessing a Reduced Lactose Internalization For Producing an Oligosaccharide EIX, EMILY FAY 43d overdue
18554108 COMPOSITION FOR INHIBITING BIOFILM COMPRISING LACTOBACILLUS RHAMNOSUS AS ACTIVE INGREDIENT FORD, VANESSA L 20d
17767851 CONTROL OF EYES FORMATION IN SWISS TYPE CHEESE AND CONTINENTAL CHEESE TYPE THAKUR, VIREN A 26d
17259792 NEW BACTERIA BARRON, SEAN C 28d
18254711 FAT ENCAPSULATED MICROBIAL CULTURES TURNER, FELICIA C 34d
19027254 LACTIC ACID BACTERIA COMPOSITION FOR PREPARING FERMENTED FOOD PRODUCTS WITH INCREASED NATURAL SWEETNESS AND FLAVOR KERSHAW, KELLY P —
18872399 INHIBITION OF SACCHAROMYCES BY PICHIA PLUYVERI MUKHOPADHYAY, BHASKAR —

Interview Candidates (13)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18559720 METHOD OF PRODUCING FERMENTED MILK PRODUCTS WITH IMPROVED TEXTURE AND REDUCED POST-ACIDIFICATION MORNHINWEG, JEFFREY P 12d
18254711 FAT ENCAPSULATED MICROBIAL CULTURES TURNER, FELICIA C 34d
19027254 LACTIC ACID BACTERIA COMPOSITION FOR PREPARING FERMENTED FOOD PRODUCTS WITH INCREASED NATURAL SWEETNESS AND FLAVOR KERSHAW, KELLY P —
18872399 INHIBITION OF SACCHAROMYCES BY PICHIA PLUYVERI MUKHOPADHYAY, BHASKAR —
18856586 Method for Producing Plant-Based Meat Analogues Using Leuconostoc Carnosum LI, CHANGQING —
18842354 METHOD FOR PREPARING CULTURES OF LACTIC ACID BACTERIA, PRODUCTS AND CULTURE MEDIA THEREFORE BERKE-SCHLESSEL, DAVID W —
18778371 PROCESS FOR PRODUCING A MESOPHILIC FERMENTED MILK PRODUCT HAWKINS, AMANDA SALATA —
18728307 Streptococcus thermophilus Strains with Improved Texturing Properties FERNANDEZ, SUSAN EMILY —

Top Art Units

Art UnitApps
1793 6
1791 4
1653 4
1792 3
1651 2
1656 2
1645 2
1657 2
1652 1
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19027254 LACTIC ACID BACTERIA COMPOSITION FOR PREPARING FERMENTED FOOD PRODUCTS WITH INCREASED NATURAL SWEETNESS AND FLAVOR KERSHAW, KELLY P 1791 §103§112DP Non-Final OA — Pending Jan 17, 2025
18872399 INHIBITION OF SACCHAROMYCES BY PICHIA PLUYVERI MUKHOPADHYAY, BHASKAR 1792 §101§103 Non-Final OA — Pending Dec 06, 2024
18856586 Method for Producing Plant-Based Meat Analogues Using Leuconostoc Carnosum LI, CHANGQING 1791 §101§103§112 Non-Final OA — Pending Oct 11, 2024
18842354 METHOD FOR PREPARING CULTURES OF LACTIC ACID BACTERIA, PRODUCTS AND CULTURE MEDIA THEREFORE BERKE-SCHLESSEL, DAVID W — §102§103§112 Non-Final OA — Pending Aug 28, 2024
18778371 PROCESS FOR PRODUCING A MESOPHILIC FERMENTED MILK PRODUCT HAWKINS, AMANDA SALATA 1793 §103§112 Non-Final OA — Pending Jul 19, 2024
18728307 Streptococcus thermophilus Strains with Improved Texturing Properties FERNANDEZ, SUSAN EMILY 1651 §112 Non-Final OA — Pending Jul 11, 2024
18722142 REDUCED PANTOTHENIC ACID LEVELS IN FERMENTATIVE PRODUCTION OF OLIGOSACCHARIDES TSAY, MARSHA M 1656 §103§112 Non-Final OA — Pending Jun 20, 2024
18713313 COMPOSITIONS FOR INCREASED STABITLITY OF BACTERIA AFREMOVA, VERA 1653 §102§103§112 Non-Final OA — Pending May 24, 2024
18713320 FAT AND WAX MICROENCAPSULATED AMBIENT STABLE BACTERIA AND PROBIOTICS AFREMOVA, VERA 1653 §103§112 Non-Final OA — Pending May 24, 2024
18688273 LOW-ALCOHOL OR ALCOHOL-FREE BEVERAGE OBTAINED WITH MALTOSE-NEGATIVE YEAST AND SUBSEQUENT DEALCOHOLIZATION CHAWLA, JYOTI 1791 §103 Final Rejection 46d Pending Feb 29, 2024
18688225 YARROWIA LIPOLYTICA AND ITS USE FOR PRODUCING LIPASES SPECIFICALLY LIBERATING SHORT CHAIN FATTY ACIDS KOHLER, STEPHANIE A 1791 §102§103§112DP Non-Final OA — Pending Feb 29, 2024
18580350 COMPOSITION FOR CLOTTING MILK, METHODS AND USES THEREOF MOAZZAMI, NAGHMEH NINA 1793 §103§112 Non-Final OA — Pending Jan 18, 2024
18559720 METHOD OF PRODUCING FERMENTED MILK PRODUCTS WITH IMPROVED TEXTURE AND REDUCED POST-ACIDIFICATION MORNHINWEG, JEFFREY P 1793 §103 Final Rejection 12d Pending Nov 08, 2023
18554108 COMPOSITION FOR INHIBITING BIOFILM COMPRISING LACTOBACILLUS RHAMNOSUS AS ACTIVE INGREDIENT FORD, VANESSA L 1645 §103§112 Non-Final OA 20d Pending Oct 05, 2023
18469188 PHARMACEUTICAL COMPOSITION COMPRISING A PROBIOTIC AND PREBIOTIC TO PREVENT ACQUISITION OF OR TREAT DRUG RESISTANT INFECTIONS HINES, JANA A 1645 §103 Non-Final OA — Pending Sep 18, 2023
18344244 Food Composition Comprising L-Fucose FRONDA, CHRISTIAN L 1652 §103 Final Rejection 44d overdue Pending Jun 29, 2023
18267958 Microbial Cells Possessing a Reduced Lactose Internalization For Producing an Oligosaccharide EIX, EMILY FAY 1653 §102§103§112 Final Rejection 43d overdue Pending Jun 16, 2023
18254711 FAT ENCAPSULATED MICROBIAL CULTURES TURNER, FELICIA C 1793 §103 Non-Final OA 34d Pending May 26, 2023
17769704 BACTERIAL COMPOSITION FOR CONTROLLING FUNGAL SPOILAGE AND USES THEREOF TURNER, FELICIA C 1793 §103 Final Rejection — Pending Apr 15, 2022
17767851 CONTROL OF EYES FORMATION IN SWISS TYPE CHEESE AND CONTINENTAL CHEESE TYPE THAKUR, VIREN A 1792 §103§112 Final Rejection 26d Pending Apr 08, 2022
17618254 PRODUCTION OF FUCOSYLATED OLIGOSACCHARIDES IN BACILLUS MARTIN, RACHEL E 1657 §103 Final Rejection — Pending Dec 10, 2021
17611338 METHODS FOR ENCAPSULATION GOTFREDSON, GAREN 1619 §103 Final Rejection 19d overdue Pending Nov 15, 2021
17512592 COMPOSITIONS OF HETERO- AND HOMOFERMENTATIVE LACTIC ACID BACTERIAL SPECIES FOR DUAL PURPOSE SILAGE PRESERVATION ZILBERING, ASSAF 1792 §103 Final Rejection — Pending Oct 27, 2021
17434967 FERMENTATIVE PRODUCTION OF CARBOHYDRATES BY MICROBIAL CELLS UTILIZING A MIXED FEEDSTOCK EDWARDS, JESSICA FAYE 1657 §103DP Final Rejection 70d overdue Pending Aug 30, 2021
17259792 NEW BACTERIA BARRON, SEAN C 1653 §101§112 Final Rejection 28d Pending Jan 12, 2021
17058803 SIMPLE METHOD FOR THE PURIFICATION OF A SIALYLLACTOSE MORNHINWEG, JEFFREY P 1793 §103 Final Rejection — Pending Nov 25, 2020
17054950 USE OF GLYCOSIDASES IN THE PRODUCTION OF OLIGOSACCHARIDES GORDON, MELENIE LEE 1651 §103 Final Rejection — Pending Nov 12, 2020
16769964 SPRAY-DRIED SIALYLLACTOSE SPANGLER, JOSEPH RANKIN 1656 §101§103Other Final Rejection 80d overdue Pending Jun 04, 2020

Managing Chr. Hansen A/S's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Chr. Hansen A/S have?

Chr. Hansen A/S has 28 pending office actions as of October 2026, spread across 10 art units and 25 examiners.

Which USPTO examiner handles the most Chr. Hansen A/S applications?

Vera Afremova has the most, with 2 of Chr. Hansen A/S's pending office actions.

What technology area are Chr. Hansen A/S's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month